Skip to main content
padlock icon - secure page this page is secure

Free Content Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV

Download Article:
 Download
(PDF 208.8 kb)
 
BACKGROUND: Despite renewed focus on molecular tuberculosis (TB) diagnostics and new antimycobacterial agents, treatment outcomes for patients co-infected with drug-resistant TB and human immunodeficiency virus (HIV) remain dismal, in part due to lack of focus on medication adherence as part of a patient-centered continuum of care.

OBJECTIVE: To review current barriers to drug-resistant TB-HIV treatment and propose an alternative model to conventional approaches to treatment support.

DISCUSSION: Current national TB control programs rely heavily on directly observed therapy (DOT) as the centerpiece of treatment delivery and adherence support. Medication adherence and care for drug-resistant TB-HIV could be improved by fully implementing team-based patient-centered care, empowering patients through counseling and support, maintaining a rights-based approach while acknowledging the responsibility of health care systems in providing comprehensive care, and prioritizing critical research gaps.

CONCLUSION: It is time to re-invent our understanding of adherence in drug-resistant TB and HIV by focusing attention on the complex clinical, behavioral, social, and structural needs of affected patients and communities.
No Reference information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: HIV; drug-resistant TB; medication adherence; patient-centered care

Document Type: Research Article

Affiliations: 1: *Division of Pulmonary Allergy and Critical Care Medicine, Columbia University Medical Center, New York , Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA, Centre for the AIDS Programme of Research in South Africa, South African Medical Research Council TB HIV Pathogenesis Extramural Unit, Durban, South Africa 2: Centre for the AIDS Programme of Research in South Africa, South African Medical Research Council TB HIV Pathogenesis Extramural Unit, Durban, South Africa, §Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada 3: Treatment Action Group, New York 4: Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA, #International Center for AIDS Care and Treatment Programs, Mailman School of Public Health, Columbia University, New York, New York 5: Department of Health Behavior and Health Education, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA 6: ††University of Cape Town, Cape Town, South Africa 7: *Division of Pulmonary Allergy and Critical Care Medicine, Columbia University Medical Center, New York 8: ‡‡Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California, USA 9: §§Médecins Sans Frontières, Mumbai, India 10: ##Touro College Graduate School of Social Work, New York, New York 11: ***Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, New York 12: Centre for the AIDS Programme of Research in South Africa, South African Medical Research Council TB HIV Pathogenesis Extramural Unit, Durban, South Africa 13: †††Harvard Medical School, Boston, Massachusetts 14: ¶¶Yale University School of Public Health, New Haven, Connecticut, ‡‡‡Yale University School of Medicine, New Haven, Connecticut, USA

Publication date: April 1, 2016

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

    Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more